17554 Federal Register / Vol. 72, No. 67 / Monday, April 9, 2007 / Notices 

hereditary genetic risk for ovarian 

cancer that the currently available 

screening modalities of CA 125 and 

transvaginal ultrasound are 

recommended. 

Statements from the scientific and 

medical community regarding 

recommendations for ovarian cancer 

screening play only a partial role in a 

woman’s decision to undergo screening 

exams. Numerous psychological and 

sociological factors can affect this 

decision as well, including a woman’s 

knowledge, attitudes, beliefs, and 

experiences. For instance, a woman’s 

experience of cancer within her family 

or experience with a friend who has had 

cancer may influence a woman’s 

screening decisions. 

The literature also notes that women 

with a family history of ovarian cancer 

report increased worry and high levels 

of perceived risk. A positive association 

has also been shown between screening 

behavior and family history. Recent 

studies indicate, however, that 

screening is not occurring in proportion 

to women’s levels of risk. These 

findings underscore the need for a better 

understanding of how perceived risk of 

ovarian cancer may influence worry 

about cancer and ultimately screening 

behavior. 

To address these issues, the Division 

of Cancer Prevention and Control 

(DCPC), at the National Center for 

Chronic Disease Prevention and Health 

Promotion, Centers for Disease Control 

and Prevention, is conducting a study to 

examine the effects of family history of 

cancer, knowledge about ovarian cancer, 

worry and/or anxiety, and perceived 

risk of cancer on the likelihood of a 

woman undergoing screening for 

ovarian cancer. By also examining other 

psycho-social factors such as a woman’s 

closeness to a relative or friend with 

cancer, coping style, cancer worry, use 

of other cancer screening tests, social 

support, and provider’s 

recommendations, the study will 

elucidate the causal pathway leading 

from actual risk (as measured by family 

history) through perceived risk to intent 

to undergo screening and actual 

screening behavior. 

The proposed study will consist of 

two tasks. In Task 1, a baseline survey 

will be administered through a 

computer-assisted telephone interview 

(CATI) program. Initially, an estimated 

32,000 women will be screened to 

determine eligibility, and then 

approximately 2000 women will be 

asked a series of questions over a 35- 

minute time period. Questions will 

cover key variables related to ovarian 

cancer screening including coping, 

anxiety, perceived risk, worry, personal 

cancer history, family cancer history, 

closeness with family or friends who 

have had cancer, screening behavior, 

and knowledge of ovarian cancer. 

In Task 2, a follow-up questionnaire 

will be administered, also using a CATI 

program, to approximately 1600 of the 

women included in the baseline 

questionnaire. Each of the women will 

be contacted one year after they 

complete the baseline survey. The 

researchers anticipate a 15 percent 

attrition of the sample between baseline 

and follow-up. In the follow-up, women 

will be asked a series of questions over 

a 15-minute time period. The purpose of 

this data collection effort is to determine 

if risk perception has changed and to 

ask about screening for ovarian cancer, 

since the baseline questionnaire was 

administered. 

All data will be collected over a threeyear time period. The total estimated 

annualized burden hours are 1,411. 

There are no costs to the respondents 

other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Group Type of respondents No. of respondents 

No. of responses per 

respondent 

Avg. burden 

per response 

(in hours) 

Eligibility Screener .......................................... Women 30 and older ..................................... 10,667 1 5/60 

Baseline Survey .............................................. Women 30 and older (high, elevated or average risk of ovarian cancer).667 1 35/60 

Follow-Up Survey ............................................ Women who completed the baseline survey 533 1 15/60 

Dated: April 3, 2007. 

Joan F. Karr, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E7–6583 Filed 4–6–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Arthritis and 

Disability: Biracial Cohort Study of 

Knee and Hip Osteoarthritis, Potential 

Extramural Project (PEP) 2007–R–06 

and Evaluating Sustainable Delivery 

Systems for Arthritis Intervention 

Programs, PEP 2007–R–08 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned SEP. 

Time and Date: 12 p.m.–4 p.m., May 14, 

2007 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the review, discussion, and 

evaluation of ‘‘Arthritis and Disability: 

Biracial Cohort Study of Knee and Hip 

Osteoarthritis,’’ Potential Extramural Project 

(PEP) 2007–R–06 and ‘‘Evaluating 

Sustainable Delivery Systems for Arthritis 

Intervention Programs,’’ PEP 2007– R–08. 

For Further Information Contact: Juliana 

Cyril, M.P.H., Ph.D., CDC, 1600 Clifton Road 

NE, Mailstop D–72, Atlanta, GA 30333, 

Telephone (404) 639–4639. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 


sroberts on PROD1PC70 with NOTICES
Federal Register / Vol. 72, No. 67 / Monday, April 9, 2007 / Notices 17555 

Dated: April 2, 2007. 

Elaine L. Baker, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–6582 Filed 4–6–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Pre-Knowledge 

of Early Hearing Detection and 

Intervention Program Process and Its 

Effect on Maternal Stress and 

Compliance With Follow-Up, Potential 

Extramural Project (PEP) 2007–R–07 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting. 

Time and Date: 12 p.m.–4 p.m., May 16, 

2007 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the review, discussion, and 

evaluation of PEP 2007–R–07, ‘‘PreKnowledge of Early Hearing Detection and 

Intervention Program Process and Its Effect 

on Maternal Stress and Compliance with 

Follow-Up.’’

For Further Information Contact: Juliana 

Cyril, M.P.H., Ph.D., Associate Director for 

Policy and Peer Review, CDC, 1600 Clinton 

Road, NE., Mailstop D72, Atlanta, GA 30333, 

telephone 404–639–4639. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: April 2, 2007. 

Elaine L. Baker, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–6588 Filed 4–6–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): 

Epidemiological Studies of Epilepsy, 

Potential Extramural Project (PEP) 

2007–R–05 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned SEP. 

Time and Date: 12 p.m.–4 p.m., May 10, 

2007 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the review, discussion, and 

evaluation of scientific merit of applications 

for ‘‘Epidemiological Studies of Epilepsy,’’

PEP 2007–R–05. 

For Further Information Contact: Juliana 

Cyril, M.P.H., Ph.D., Associate Director for 

Policy and Peer Review, CDC, 1600 Clifton 

Road, NE., Mailstop D–72, Atlanta, GA 

30333, Telephone (404) 639–3098. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: April 2, 2007. 

Elaine L. Baker, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–6589 Filed 4–6–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel: NIOSH Education and 

Research Center, Program 

Announcement Number (PAR) 06–485 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following Meeting of the 

aforementioned Special Emphasis 

Panel: 

Time and Date: 10 a.m.–1 p.m., April 24, 

2007 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Purpose: The work groups which were 

convened at specific sites listed below 

advised and made recommendations to the 

Disease, Disability, and Injury Prevention 

and Control SEP: NIOSH Education and 

Research Center, PAR 06–485. Specifically, 

the SEP makes recommendations regarding 

policies, strategies, and funding. 

TIMES, DATES, AND PLACES OF THE WORK GROUP MEETINGS

8 a.m.–5 p.m. .......... November 13, 2006 (Closed) ................ Women’s Faculty Club on the University of California Berkeley campus 510–

642–4175. 

8 a.m.–5 p.m. .......... November 28, 2006 (Closed) ................ University of Alabama at Birmingham, Administration Building Penthouse, 701 

20th Street South, 14th floor, Conference Room 1, 205–934–0771. 

8 a.m.–5 p.m. .......... December 11, 2006 (Closed) ................ Bloomberg School of Public Health, 615 N. Wolfe St, Baltimore, MD 21205. 

8 a.m.–5 p.m. .......... December 14, 2006 (Closed) ................ College of Public Health 13201 Bruce B. Downs Blvd Tampa, FL 33612. 

8 a.m.–5 p.m. .......... January 9, 2007 (Closed) ...................... Fitzsimons Campus, Nighthorse Campbell Building. Room 304 Denver, CO. 

8 a.m.–5 p.m. .......... January 16, 2007 (Closed) .................... Coffman Memorial Union 300 Washington Ave. SE Minneapolis, MN 55455. 

8 a.m.–5 p.m. .......... February 13, 2007 (Closed) .................. University Park Marriott 480 Wakara Way Salt Lake City, UT 84108 801–584–

3312. 

Matters to be Discussed: The SEP meeting 

will include the review, discussion, and 

evaluation of research grant applications in 

response to ‘‘NIOSH Education and Research 

Center,’’ PAR 06–485. 

For Further Information Contact: Dr. 

Charles N. Rafferty, Ph.D., B.S., Scientific 

Review Administrator, 1600 Clifton Road NE, 

MS E74, Atlanta, GA, 30333, telephone 

404.498.2582. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 


sroberts on PROD1PC70 with NOTICES